(Q87923815)

English

Randomized phase II study of nintedanib in metastatic castration-resistant prostate cancer postdocetaxel

scientific article published on 01 October 2014

Statements

Randomized phase II study of nintedanib in metastatic castration-resistant prostate cancer postdocetaxel (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit